177735-10-3Relevant academic research and scientific papers
Photoinduced Four-State Three-Step Ordering Transformation of Photochromic Terthiophene at a Liquid/Solid Interface Based on Two Principles: Photochromism and Polymorphism
Yokoyama, Soichi,Hirose, Takashi,Matsuda, Kenji
, p. 6404 - 6414 (2015/06/30)
We have investigated photoinduced ordering transformation of a photochromic terthiophene derivative by scanning tunneling microscopy (STM) at the trichlorobenzene (TCB)/highly oriented pyrolytic graphite (HOPG) interface. The open-ring and annulated isomers of the terthiophene formed two-dimensional molecular orderings with different patterns while the closed-ring isomer did not form any ordering. The ordering of the open-ring isomer exhibited polymorphism depending on the concentration of supernatant solution. Upon UV light irradiation to a solution of the open-ring isomer or the closed-ring isomer, ordering composed of the annulated isomer was irreversibly formed. Upon visible light irradiation or thermal stimulus to the closed-ring isomer, the two kinds of polymorph composed of the open-ring isomer were formed due to the polymorphism. By controlling photochromism and polymorphism among four states made of three photochemical isomers, four-state three-step transformation was achieved by in situ photoirradiation from a solution of the closed-ring isomer (no ordering) into the ordering composed of the open-ring isomer (ordering α and β) followed by the orderings composed of the annulated isomer (ordering γ).
Synthetic protocol for diarylethenes through Suzuki-Miyaura coupling
Hiroto, Satoru,Suzuki, Katsuya,Kamiya, Hiroki,Shinokubo, Hiroshi
supporting information; experimental part, p. 7149 - 7151 (2011/09/12)
The synthesis of a variety of diarylethenes through the Suzuki-Miyaura coupling reaction of 1,2-dichlorohexafluorocyclopentene with arylboronic acids and esters has been developed. Thiophenes with various substituents such as cyano and ester functionalities can be incorporated.
IMIDAZOPYRIDAZINE COMPOUNDS
-
, (2008/06/13)
The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I): pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.
